Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
European Research Council
Vetenskapsrådet
Knut och Alice Wallenbergs Stiftelse
Marianne and Marcus Wallenberg Foundation
Strategic Research Area MultiPark (Multidisciplinary Research in Parkinson’s disease) at Lund University
Swedish Alzheimer Foundation
Hjärnfonden
Parkinson foundation of Sweden
Skåne University Hospital Foundation
the Swedish federal government under the ALF agreement
- License Information
-
More Information
Article History
Received: 12 February 2019
Accepted: 8 July 2019
First Online: 19 July 2019
Ethics approval and consent to participate
: De-identified CSF samples from 53 patients were used in this study. All patients gave their written informed consent allowing their CSF samples to be used for research.
: Not applicable.
: Drs Janelidze and Stomrud declare that they have no competing interests. Dr. Brix is employed by Euroimmun. Dr. Hansson has acquired research support (for the institution) from Roche, GE Healthcare, Biogen, AVID Radiopharmaceuticals, Fujirebio, and Euroimmun. In the past 2 years, he has received consultancy/speaker fees (paid to the institution) from Biogen, Roche, and Fujirebio.
